03 · What You Need to Know
Not All Eligibility Criteria Protect Against the Same Kind of Problem
Start With the Exact Criterion That Was Not Met
Do not begin with the vague statement “the participant was ineligible.” Identify precisely which inclusion criterion was not satisfied or which exclusion criterion applied.
Then verify what the approved protocol actually says. Eligibility rules can contain ranges, timing requirements, diagnostic definitions, screening thresholds, exceptions, or other details that are easily misremembered. Confirm the current approved protocol before concluding that a deviation occurred.
Research investigators are expected to conduct approved research consistently with the IRB-approved plan, and permanent changes to eligibility criteria generally should be handled prospectively rather than informally changing the criteria after someone has been enrolled.
Ask Why the Criterion Exists
This is often the most important analytical step. An exclusion criterion may exist because participation could be unsafe for people with a particular medical condition. Another may define the target population necessary to answer the research question. A third may prevent confounding. A fourth may reflect legal, consent, developmental, or logistical considerations.
Safety-related criterion
Helps prevent participants with particular characteristics or conditions from being exposed to research-related risks considered unacceptable for them.
Scientific criterion
Defines the population or controls factors important to the validity, interpretability, or purpose of the research.
In practice, these categories can overlap. The reason for the criterion should be established from the protocol, investigator brochure where applicable, scientific rationale, ethics documentation, or other authoritative study materials rather than guessed after the event.
A Safety-Related Eligibility Error May Require Immediate Action
If the missed criterion exists to prevent a known or plausible participant risk, participant protection takes priority over administrative classification.
Suppose an interventional study excludes people taking a medication because of a potentially dangerous interaction. If a participant taking that medication has already received the study intervention, the team should promptly assess the participant's clinical situation and follow the relevant safety procedures. Waiting to complete a deviation form before addressing the participant would rather miss the point.
ICH E6(R3) emphasizes protection of trial participants' rights, safety, and well-being and expects investigators to conduct trials in compliance with the approved protocol. It also recognizes circumstances in which deviations may be necessary to eliminate immediate hazards.
A Scientifically Important Criterion Still Matters Even When Safety Is Unchanged
Some eligibility errors introduce little additional participant risk but affect the scientific integrity of the study.
Imagine a study explicitly examining first-year teachers, but one participant has six years of teaching experience. Participation may pose no additional risk, yet the participant does not belong to the population the study was designed to investigate.
The event still requires appropriate documentation and assessment. The research team may need to determine how the participant's data should be handled analytically and whether the error reveals a weakness in screening procedures.
Do Not Automatically Withdraw the Participant
Discovering ineligibility does not itself establish that immediate withdrawal is always the safest or most ethical response. In some studies, stopping participation may be straightforward. In others, abrupt discontinuation of a study intervention could itself create risk, or continued safety follow-up may remain necessary even if further protocol treatment stops.
The decision should therefore reflect participant welfare, the protocol, clinical judgment where relevant, sponsor instructions, ethics requirements, and applicable regulations.
Likewise, do not continue participation merely because the participant has already begun. The fact that an error has occurred does not authorize further departures from the approved protocol.
Do Not Quietly Change the Eligibility Criteria Retrospectively
A particularly problematic response is to discover an ineligible participant and then rewrite the eligibility criteria so that the participant appears eligible after all.
If the research team concludes that the criterion is unnecessarily restrictive and wants future participants with the same characteristic to enroll, that is a proposed protocol change. Under U.S. HHS requirements, changes to approved research generally require prior IRB review and approval before implementation, except when necessary to eliminate apparent immediate hazards.
The earlier enrollment remains a departure that should be handled according to the applicable deviation process. A prospective amendment may change future eligibility, but it does not rewrite what the approved protocol required when the participant was enrolled.
Determine What the Participant Has Already Experienced
The response depends partly on how far participation has progressed. Someone identified as ineligible immediately after consent but before any research procedure is in a different position from someone who has completed several study visits or received an investigational intervention.
Establish the chronology: screening, consent, enrollment, randomization where applicable, procedures performed, intervention received, specimens collected, information obtained, and any follow-up already completed.
This timeline helps determine immediate participant needs, reportability, data handling, and corrective action.
The Participant May Need Additional Information
Depending on the nature of the eligibility error and what happens next, the participant may need to be informed. For example, a safety-related discovery may be relevant to their continued participation or medical management.
How and when to communicate should reflect the nature of the study, participant welfare, applicable clinical responsibilities, and instructions from the responsible ethics committee or sponsor where needed.
Do not assume that every administrative eligibility error requires the same disclosure conversation, but do not conceal information that is material to the participant's safety or continued decision to participate.
Determine Whether the Event Requires Prompt Reporting
An eligibility deviation can meet reporting thresholds when it affects participant rights, safety, welfare, or constitutes an unanticipated problem, serious or continuing noncompliance, or another category identified by the responsible ethics committee.
Under U.S. HHS requirements, institutions must maintain procedures for prompt reporting of unanticipated problems involving risks to participants or others and serious or continuing noncompliance. OHRP guidance also recognizes modification of inclusion or exclusion criteria as one possible response when newly identified risks require changes to the protocol.
The applicable reporting decision should follow the criteria described for reporting protocol deviations to the ethics committee.
Determine What Happens to the Participant's Data
Researchers sometimes assume that an ineligible participant's data must automatically be deleted. That is not a universal rule.
Data handling can depend on the protocol, consent, study design, sponsor or regulatory requirements, ethics determinations, and methodological considerations. In some settings, data may need to remain in safety records even if excluded from a particular analysis. In others, an ineligible participant's data may be handled according to prespecified analysis rules.
Do not silently remove inconvenient data to make the study appear protocol-compliant. Preserve an accurate study record and determine the appropriate analytical treatment transparently.
Investigate How Screening Failed
Once immediate participant issues have been addressed, investigate the cause. Was a screening question ambiguous? Was a laboratory result overlooked? Did staff misunderstand the criterion? Was source information unavailable? Did the participant provide inaccurate information? Did an electronic eligibility check fail?
The corrective response should fit the cause. Retraining staff will not fix an ambiguous screening form. Adding another checklist will not solve an eligibility criterion that nobody can operationalize consistently.
One Error Can Reveal a Larger Screening Problem
After discovering an ineligible participant, consider whether other enrolled participants could have been affected by the same failure. A misunderstood criterion, faulty screening formula, incorrect laboratory reference range, or software error may have been applied repeatedly.
If the problem is systematic, review relevant enrollment records and determine whether additional participants were incorrectly classified. Repeated departures may raise broader concerns about continuing noncompliance or whether actual study conduct has diverged from the approved protocol.
Watch Out
Do not make the participant disappear from the research record simply because their enrollment was erroneous. Preserve the audit trail, document what occurred, and determine participant management, reporting, and data handling through the procedures applicable to the study.
